BioSpace News Archive

Healthcare AI specialist, Clinithink, delivers ‘hours to minutes’ ground-breaking analysis to save vital time in the care of sick newborns with rare disease

Clinithink’s advanced AI technology has enabled clinicians at RCIGM, a world leader in the field of genomics, to perform the deep phenotyping of a critically ill five-week-old baby with an unknown condition within minutes to help identify his rare genetic disorder.

June 24, 2021
·
4 min read
Business

Adverum Announces Changes to Management Team

Adverum Biotechnologies, Inc. today announced that Leone Patterson, president and chief financial officer, has resigned to pursue another opportunity.

June 24, 2021
·
5 min read
GENFIT obtains non-dilutive financing of €11 million in the form of a State Guaranteed Loan

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, announced the securing of a €11 million non-dilutive loan guaranteed by the French government.

June 24, 2021
·
5 min read
Pharm Country

Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), , today announced the closing of its previously announced registered direct offering to Deep Track Capital for the issuance and sale of an aggregate of 2,380,953 shares of its common stock

June 24, 2021
·
4 min read
Business

Aethlon Medical Announces Fiscal Year End Financial Results 2021 and Provides Corporate Update

Aethlon Medical, Inc.Aethlon Medical, Inc., a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported financial results for its fiscal year ended March 31, 2021 and provided an update on recent developments.

June 24, 2021
·
11 min read
Bio NC

IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials

IQVIA™ (NYSE: IQV) today introduced Clinical Data Analytics Suite (CDAS) , a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use.

June 24, 2021
·
3 min read
Deals

Theravance Biopharma, Inc. Announces Proposed Public Offering of Ordinary Shares

Theravance Biopharma, Inc. announced today that it intends to offer its ordinary shares in an underwritten public offering.

June 24, 2021
·
3 min read
FDA

Mirati Therapeutics’ Adagrasib Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Patients with Advanced Non-Small Cell Lung Cancer Harboring the KRAS G12C Mutation

Mirati Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the potential treatment of patients with non-small cell lung cancer (NSCLC) who harbor the KRAS G12C mutation.

June 24, 2021
·
5 min read
Business

Endo to Announce Second Quarter 2021 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second–quarter 2021 financial results on August 5, 2021 after the U.S. financial markets close and members of its senior management team will host a conference call and webcast on August 6, 2021 at 7:30am ET before the U.S. financial markets open.

June 24, 2021
·
1 min read
Policy

Adial Pharmaceuticals Provides Regulatory and Development Update

Adial Pharmaceuticals, Inc. today announced that it has received correspondence related to its request for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate, AD04.

June 24, 2021
·
6 min read